AU Patent

AU2016251940C1 — Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate

Assigned to Pfizer Inc · Expires 2019-04-11 · 7y expired

What this patent protects

This invention relates to a crystalline form of 1-((

USPTO Abstract

This invention relates to a crystalline form of 1-((

Drugs covered by this patent

Patent Metadata

Patent number
AU2016251940C1
Jurisdiction
AU
Classification
—
Expires
2019-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.